Advertisement

Topics

PubMed Journals Articles About "Glanbia Nutritionals Pharmaceuticals Healthcare Deals Alliances Profile Prices" RSS

13:51 EDT 25th June 2018 | BioPortfolio

Glanbia Nutritionals Pharmaceuticals Healthcare Deals Alliances Profile Prices PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Glanbia Nutritionals Pharmaceuticals Healthcare Deals Alliances Profile Prices articles that have been published worldwide.

More Information about "Glanbia Nutritionals Pharmaceuticals Healthcare Deals Alliances Profile Prices" on BioPortfolio

We have published hundreds of Glanbia Nutritionals Pharmaceuticals Healthcare Deals Alliances Profile Prices news stories on BioPortfolio along with dozens of Glanbia Nutritionals Pharmaceuticals Healthcare Deals Alliances Profile Prices Clinical Trials and PubMed Articles about Glanbia Nutritionals Pharmaceuticals Healthcare Deals Alliances Profile Prices for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Glanbia Nutritionals Pharmaceuticals Healthcare Deals Alliances Profile Prices Companies in our database. You can also find out about relevant Glanbia Nutritionals Pharmaceuticals Healthcare Deals Alliances Profile Prices Drugs and Medications on this site too.

Showing "Glanbia Nutritionals Pharmaceuticals Healthcare Deals Alliances Profile Prices" PubMed Articles 1–25 of 6,500+

Killing U.S. Slowly: Curing the Epidemic Rise of Cancer Drug Prices.

In August 2015, more than 110 U.S. oncologists published an article detailing the deleterious effects of rising cancer drugs prices and calling for numerous reforms to our prescription drug system. These prices are the result of decades of political maneuvering; they reflect the way our country has chosen to pay for healthcare, to foster and reward innovation, and to promote a national free market system. While these choices have resulted in immense profits for pharmaceutical companies—and subsidized the ...


Thresholds for decision-making: informing the cost-effectiveness and affordability of rotavirus vaccines in Malaysia.

Cost-effectiveness thresholds (CETs) based on the Commission on Macroeconomics and Health (CMH) are extensively used in low- and middle-income countries (LMICs) lacking locally defined CETs. These thresholds were originally intended for global and regional prioritization, and do not reflect local context or affordability at the national level, so their value for informing resource allocation decisions has been questioned. Using these thresholds, rotavirus vaccines are widely regarded as cost-effective inter...

What Is Bending the Cost Curve? An Exploration of Possible Drivers and Unintended Consequences.

Health expenditures in most OECD countries have increased at a slower rate since 2008/2009. Potential drivers of this bending of the cost curve include: (1) changes in pharmaceuticals and technology innovations; (2) healthcare reforms, and specifically those focusing on care for complex and high-user patients and (3) government expenditure controls resulting from general economic conditions. We use publicly available National Health Expenditure data from the Canadian Institute for Health Information to asse...


Pricing of monoclonal antibody therapies: higher if used for cancer?

The rising prices of specialty drugs have prompted a debate about how medications are priced. With the average price of cancer drugs doubling in the last decade, the unsustainability of drug prices is especially concerning in oncology and hematology. The objective of this study was to compare the prices of monoclonal antibodies (mAbs) approved in the last 20 years by the FDA across disease states.

How to prevent the next Marathon Pharmaceuticals.

In recent years, several drug companies have exploited U.S. regulatory policies to acquire exclusive rights to cheap therapies and substantially raise their prices, and Federal agencies and state governments are exploring various ways to prevent or punish such behavior in the future. Among these cases, however, Marathon Pharmaceuticals' handling of Emflaza (deflazacort) is unique, because the drug was previously only available abroad, and was never previously sold in the U.S. before the company obtained FDA...

Cardiovascular Risk Profile of Transgender Women with HIV: A U.S. Healthcare Database Study.

We sought to characterize the cardiovascular disease (CVD) risk factor profile of transgender women with HIV identified through a U.S. healthcare database. Compared with age- and race-matched cisgender men with HIV, transgender women with HIV had an increased prevalence of anemia and lower absolute hemoglobin levels. HIV control was sub-optimal and prevalence of HCV co-infection was high among transgender women. Further study of non-traditional CVD risk factors/immune activation among transgender women with...

The Second Society for Simulation in Healthcare Research Summit: Beyond our Boundaries.

In this article, we report on the Second Society for Simulation in Healthcare Research Summit held in 2017. This meeting succeeded the First Research Summit from 2011 with the goal of advancing the scope of healthcare simulation research. During the one and a half day summit, some of the world's leading experts in simulation, healthcare, and simulation in healthcare convened to discuss ideas about what research goals would be most beneficial to the healthcare simulation community, and what could be done to ...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Janssen, Millennium Pharmaceuticals, and Onyx Pharmaceuticals; and is a member of advisory boards for Amgen, Bristol-Myers Squibb, Celgene Corporation, Incyte, Kite, Legend Biotech, Sanofi-Aventis, and Takeda Pharmaceuticals.

Funding breakthrough therapies: A systematic review and recommendation.

Advanced therapy medicinal products (ATMPs) are innovative therapies likely associated with high prices. Payers need guidance to create a balance between ensuring patient access to breakthrough therapies and maintaining the financial sustainability of the healthcare system.

Help wanted: industry seeks science alliances.

A Health Profile of Senior-Aged Women Veterans: A Latent Class Analysis of Condition Clusters.

This study characterizes the multiple morbidities experienced by senior-aged women Veterans so that the Veterans Health Administration (VHA) and other healthcare systems may be better prepared to meet the healthcare needs of this growing cohort.

Strong alliances to improve stroke care.

Health-industry linkages for local health: reframing policies for African health system strengthening.

The benefits of local production of pharmaceuticals in Africa for local access to medicines and to effective treatment remain contested. There is scepticism among health systems experts internationally that production of pharmaceuticals in sub-Saharan Africa (SSA) can provide competitive prices, quality and reliability of supply. Meanwhile low-income African populations continue to suffer poor access to a broad range of medicines, despite major international funding efforts. A current wave of pharmaceutical...

A Future-Focused Approach to Behavioral Healthcare.

Predictability of machine learning techniques to forecast the trends of market index prices: Hypothesis testing for the Korean stock markets.

The prediction of the trends of stocks and index prices is one of the important issues to market participants. Investors have set trading or fiscal strategies based on the trends, and considerable research in various academic fields has been studied to forecast financial markets. This study predicts the trends of the Korea Composite Stock Price Index 200 (KOSPI 200) prices using nonparametric machine learning models: artificial neural network, support vector machines with polynomial and radial basis functio...

Interview With Rulon F. Stacey, PhD, FACHE, Managing Director, Healthcare, Navigant Consulting.

White House Report on Drug Prices Is a Detailed Road Map: Price-Lowering Ideas Generated, Some Already in Motion.

White House report on drug prices is a detailed road map.

Practitioner Application: Ten CEO Imperatives for Healthcare Transformation: Lessons From Top-Performing Academic Medical Centers.

Healthcare use for children with complex needs: using routine health data linked to a multiethnic, ongoing birth cohort.

Congenital anomaly (CA) are a leading cause of disease, death and disability for children throughout the world. Many have complex and varying healthcare needs which are not well understood. Our aim was to analyse the healthcare needs of children with CA and examine how that healthcare is delivered.

Drug Policy in Estonia.

The aim of this article was to present a general overview of the health care system as well as pricing and reimbursement environment in Estonia. In Estonia the main stakeholders in the pharmaceutical sector are the Ministry of Social Affairs, the State Agency of Medicine, and the Estonian Health Insurance Fund. The national health insurance scheme is public, and approximately 95% of the population is covered by it. It is a social insurance, and universal and equal access to health care based on national hea...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause of familial hypercholesterolemia. However, multiple mutations in various other genes are also associated with high LDL cholesterol and even familial hypercholesterolemia. Thus, pharmaceuticals that target these genes and proteins might be attractive treatment options to reduce LDL cholesterol. This review provi...

The role of personal resilience and personality traits of healthcare students on their attitudes towards interprofessional collaboration.

Interprofessional collaboration (IPC) improves communication between healthcare workers and healthcare delivery. Interprofessional education (IPE) is essential in preparing healthcare students for cooperating with other healthcare disciplines in a real work setting. Although higher education settings have a responsibility to provide collaborative healthcare practice to students, IPE has not yet been prompted worldwide as a formal division in health professional education and in Israel IPE among health profe...

Alcohol taxes' contribution to prices in high and middle-income countries: Data from the International Alcohol Control Study.

Taxation is increasingly being used as an effective means of influencing behaviour in relation to harmful products. In this paper we use data from six participating countries of the International Alcohol Control Study to examine and evaluate their comparative prices and tax regimes.

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product related caused by protein degradation occurring throughout the life history of a product. Although the pharmaceutical biotechnology industry has made great progress in improving bulk and drug product manufacturing as well as company-controlled storage and transportation conditions to minimize the level of degra...

A low-complexity add-on score for protein remote homology search with COMER.

Protein sequence alignment forms the basis for comparative modeling, the most reliable approach to protein structure prediction, among many other applications. Alignment between sequence families, or profile-profile alignment, represents one of the most, if not the most, sensitive means for homology detection but still necessitates improvement. We aim at improving the quality of profile-profile alignments and the sensitivity induced by them by refining profile-profile substitution scores.


Advertisement
Quick Search
Advertisement
Advertisement